Celldex Therapeutics - Precision Targeted Immunotherapies > News & Events

  • Celldex Overview
    • Goals & Strategy
    • Executive Officers
    • Board of Directors
    • Scientific Advisory Board
    • APC Technology Platform
    • Strategic Alliances
    • Intellectual Property
  • Clinical Pipeline
    • Cancer
    • Infectious Disease
    • Autoimmune Disease
    • Biodefense
  • APC Technology
    • APC Targeting
    • Notch Technology
  • Clinical Trials
    • Cancer – Current Trials
  • Investors
  • News & Events
    • Media Kit
    • Scientific Articles
  • Careers
    • A Great Place to Work
    • Benefits
    • Current Opportunities
  • Media Kit
  • Scientific Articles

Media Contact

Ronald C Newbold
Vice President,
Business Development

Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865

Phone: 908-454-7120 X312
rnewbold@
celldextherapeutics.com

News & Events

2008 > 2007 > 2006 > 2005 > 2004
  • April 16, 2008
    AVANT to Host Conference Call Today, April 16, 2008, at 5:00 P.M. to Discuss CDX-110 Partnership with PFIZER
  • April 16, 2008
    PFIZER and AVANT Enter Into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
  • January 7, 2008
    Celldex Therapeutics Receives Fast-track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
Celldex Press Releases 2008

Print Page

©2008 Celldex, Inc | Legal Information | Privacy Policy
Contact Site Map
Search